EGFR and neoplasm: Here, we report the largest EGFR–METex14 co-mutation series to date-seven tumours diagnosed between 2019 and 2024 at three Chinese tertiary hospitals—and compare them with 12 METex14-only and 709 EGFR-only cohorts.